Search Results - "Campiglio, M."

Role of exon-16-deleted HER2 in breast carcinomas by Castiglioni, F, Tagliabue, E, Campiglio, M, Pupa, S M, Balsari, A, Ménard, S

“…A splice variant of the human gene HER2, lacking exon-16 (ΔHER2) which encodes a small extracellular region, has been described. This altered receptor forms…”
Get full text

Role of HER2/neu in tumor progression and therapy by Ménard, S, Casalini, P, Campiglio, M, Pupa, S M, Tagliabue, E

“…HER2 (human epidermal growth factor receptor-2; also known as erbB2) and its relatives HER1 (epidermal growth factor receptor; EGFR), HER3 and HER4 belong to…”
Get full text

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth by NORMANNO, N, CAMPIGLIO, M, DE LUCA, A, SOMENZI, G, MAIELLO, M, CIARDIELLO, F, GIANNI, L, SALOMON, D. S, MENARD, S

“…Co-expression of the epidermal growth factor receptor (EGFR) and of ErbB-2 is found in a subset of primary human breast cancer. The antiproliferative effects…”
Get full text

Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab by Campiglio, M., Sandri, M., Sasso, M., Bianchi, F., Balsari, A., Ménard, S., Tagliabue, E.

Get full text

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer by Ménard, S., Casalini, P., Campiglio, M., Pupa, S., Agresti, R., Tagliabue, E.

“…To date, poor standardization in HER2 status evaluation has precluded reliable comparison of overexpression rates in different tumors. However, standardized…”
Get full text

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1 by Berno, V, Porrini, D, Castiglioni, F, Campiglio, M, Casalini, P, Pupa, S M, Balsari, A, Ménard, S, Tagliabue, E

“…The association between expression of the 67 kDa laminin receptor (67LR) and tumor aggressiveness has been convincingly demonstrated although the exact…”
Get full text

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study by Campiglio, M., Bufalino, R., Sasso, M., Ferri, E., Casalini, P., Adamo, V., Fabi, A., Aiello, R., Riccardi, F., Valle, E., Scotti, V., Tabaro, G., Giuffrida, D., Tarenzi, E., Bologna, A., Mustacchi, G., Bianchi, F., Balsari, A., Ménard, S., Tagliabue, E.

“…Clinical trials have shown the efficacy of trastuzumab-based adjuvant therapy in HER2-positive breast cancers, but routine clinical use awaits evaluation of…”
Get full text

168 CDCP1 as a new marker of aggressiveness in triple-negative breast cancers by Campiglio, M, Turdo, F, Bianchi, F, Sasso, M, de Cecco, L, Casalini, P, Gasparini, P, Forte, L, Agresti, R, Maugeri, I, Sozzi, G, Tagliabue, E

Get full text

243 Triple Negative Breast Carcinoma Cells Directly Contribute to Tumor Vasculature by Endothelial Differentiation Capability by Plantamura, I, Iorio, M.V, Tortoreto, M, Triulzi, T, Casalini, P, Sasso, M, Campiglio, M, Tripodo, C, Balsari, A, Tagliabue, E

Get full text

BHLHB3: a candidate tumor suppressor in lung cancer by Falvella, F S, Colombo, F, Spinola, M, Campiglio, M, Pastorino, U, Dragani, T A

“…BHLHB3 is a basic helix-loop-helix (bHLH) domain-containing protein that acts as a transcriptional repressor. We found that BHLHB3 transcript levels were low…”
Get full text

Is the gefitinib plus trastuzumab combination feasible in breast cancer patients? by Normanno, N., Campiglio, M., Perrone, F., De Luca, A., Menard, S.

Get full text

Prediction of response to therapy by biomolecular markers: from the research laboratory to the clinic by Ménard, S., Campiglio, M., Balsari, A.

Get full text

Oncogenic protein tyrosine kinases: Role of HER2/neu in tumor progression and therapy by M nard, S., Casalini, P., Campiglio, M., Pupa, S. M., Tagliabue, E.

“…HER2 (human epidermal growth factor receptor-2; also known as erbB2) and its relatives HER1 (epidermal growth factor receptor; EGFR), HER3 and HER4 belong to…”
Get full text

Re: Effect of Epidermal Growth Factor Receptor Inhibitor on Development of Estrogen Receptor–Negative Mammary Tumors by Campiglio, Manuela, Normanno, Nicola, Ménard, Sylvie

“…data that ZD1839 does not only treat cryptic invasive cancers. We favor the interpretation that ZD1839 suppresses ER-…”
Get full text

Increasing doxorubicin antitumor activity through COX-2 inhibition without increasing cardiotoxicity by Bianchi, F, Campiglio, M, Sasso, M, Ghirelli, C, Tagliabue, E, Cairo, G, Salvatorelli, E, Minotti, G, Menna, P, Ménard, S

Get full text

Structural and functional domains critical for constitutive activation of the HGF-receptor (Met) by Zhen, Z, Giordano, S, Longati, P, Medico, E, Campiglio, M, Comoglio, P M

“…The MET gene, encoding the tyrosine kinase receptor for Hepatocyte Growth Factor, is a potentially harmful oncogene overexpressed in a significant fraction of…”
Get more information

STAC3 incorporation into skeletal muscle triads occurs independent of the dihydropyridine receptor by Campiglio, Marta, Kaplan, Mehmet M., Flucher, Bernhard E.

“…Excitation‐contraction (EC) coupling in skeletal muscles operates through a physical interaction between the dihydropyridine receptor (DHPR), acting as a…”
Get full text

P20 HER2-amplified breast carcinomas: molecular characteristic and response to trastuzumab treatment by Campiglio, M, Orlandi, R, De Cecco, L, Gariboldi, M, Bertola, L, Méenard, S, Tagliabue, E

Get full text

MicroRNA gene expression deregulation in human breast cancer by IORIO, Marilena V, FERRACIN, Manuela, MENARD, Sylvie, PALAZZO, Juan P, ROSENBERG, Anne, MUSIANI, Piero, VOLINIA, Stefano, NENCI, Italo, COLIN, George A, QUERZOLI, Patrizia, NEGRINI, Massimo, CROCE, Carlo M, LIU, Chang-Gong, VERONESE, Angelo, SPIZZO, Riccardo, SABBIONI, Silvia, MAGRI, Eros, PEDRIALI, Massimo, FABBRI, Muller, CAMPIGLIO, Manuela

“…MicroRNAs (miRNAs) are a class of small noncoding RNAs that control gene expression by targeting mRNAs and triggering either translation repression or RNA…”
Get full text

Production of a monoclonal antibody directed against the recombinant SEL1L protein by ORLANDI, R, CATTANEO, M, TROGLIO, F, CAMPIGLIO, M, BIUNNO, I, MDNARD, S

“…SEL1L, highly similar to the C elegans sel-1 gene, is a recently cloned human gene whose function is under investigation. SEL1L is differentially expressed in…”
Get full text